Search Results 311-320 of 6247 for younkin
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
ROCHESTER, Minnesota — Dr. Eric Moore has been appointed medical director, International at Mayo Clinic. Dr. Moore will begin his new position in April.
Arm 1: Reduced intensity conditioning allogeneic hematopoietic cell transplantation (RIC-alloHCT),. Arm 2: Non-Transplant Therapy/Best Supportive Care.
About this study. This is an open-label, Phase 1b, platform study in subjects with advanced or metastatic solid tumors. The study will be divided into 2 ...
The purpose of this study is to determine the performance of the Exact IBD-ACRN (inflammatory bowel disease-advanced colorectal neoplasia)surveillance test to ...
Drugs used as chemotherapy, such as carboplatin, etoposide, and ifosfamide work in different ways to stop the growth of tumor cells, either by killing the cells ...
Mayo Clinic's Bone Injury and Repair Lab, led by Abhishek Chandra, Ph.D., M.S., is developing practical therapies to mitigate osteoporosis induced by ...
About this study. In an effort to understand the effects of evidence-based interventions on children and adolescents, the aims of this study are to 1) ...
About this study. The study seeks to assess the efficacy of veliparib (ABT-888) in combination with carboplatin and etoposide in participants with extensive ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The deadline to have twice the impact to advance healthcare research is May 15.